However, the strong anti-tumor responses of STING agonists, including cGAMP, may be dampened by the rapid degradation of cGAMP by ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1). The gene discussed is ENPP1; the disease is neoplasm.